2014 Deep Research Report on Global and China Hemodialysis Concentrates Industry

Published in ; US $ 2200 Onwards; Publisher: QYResearch Group

This is a professional and depth research report on Global and China Hemodialysis Concentrates industry. The report firstly introduced Hemodialysis Concentrates basic information included Hemodialysis Concentrates definition classification application industry chain structure industry overview; inte[...]

2014 Deep Research Report on Global and China Acne Medication Industry

Published in ; US $ 2200 Onwards; Publisher: QYResearch Group

This is a professional and depth research report on Global and China Acne Medication industry. The report firstly introduced Acne Medication basic information included Acne Medication definition classification application industry chain structure industry overview; international market analysis, Chi[...]

Global Hyaluronic Acid (HA) Market 2014-2018

Published in ; US $ 2500 Onwards; Publisher: Infiniti Research Limited

Hyaluronic acid (HA) or glass acid is a naturally occurring non-sulfated glycosaminoglycan. It is present in the human body in the joints, eye cavity, and internal defense systems. It functions as a nutrient carrier, along with helping the tissues in retaining water. It is an integral part of the ex[...]

Venezuela Pharmaceuticals and Healthcare Report Q4 2014

Published in ; US $ 1295 Onwards; Publisher: Business Monitor International

BMI View: Venezuela's improving foreign currency supply, increasing pharmaceutical imports from political allies and the potential expansion of free medicine coverage in the public sector will ease the shortage of local medicines in the near term. However, fundamental issues - such as pr[...]

United Kingdom Pharmaceuticals and Healthcare Report Q4 2014

Published in ; US $ 1295 Onwards; Publisher: Business Monitor International

BMI View: The decline in NHS pharmaceutical expenditure in 2013, despite an increase in prescription numbers, does not come as a surprise and is expected to continue beyond 2014. This drop in spending reflects the UK government's focus on containing costs within the healthcare sector, an[...]

Switzerland Pharmaceuticals and Healthcare Report Q4 2014

Published in ; US $ 1295 Onwards; Publisher: Business Monitor International

BMI View: Most of Switzerland's demographic and economic indicators are favourable towards increased pharmaceutical and healthcare spending. The proportion of the pensionable population is high and growing, and this will translate into greater demand for drugs. Furthermore, the country's[...]

Qatar Pharmaceuticals and Healthcare Report Q4 2014

Published in ; US $ 1295 Onwards; Publisher: Business Monitor International

BMI View: The reduction of a large number of medicine prices in Qatar is likely to be detrimental to pharmaceutical companies' revenue potential. New drug pricing - which was previously very high in the country - will increase the volume of sales, as medicines will become more affordable[...]

Portugal Pharmaceuticals and Healthcare Report Q4 2014

Published in ; US $ 1295 Onwards; Publisher: Business Monitor International

BMI View: Despite Portugal's stronger-than-expected economic expansion in previous quarters, government austerity measures will continue to weigh on drug spending over the medium term. This is reflected in recent agreements between the Portuguese government and the pharmaceutical industr[...]

Morocco Pharmaceuticals and Healthcare Report Q4 2014

Published in ; US $ 1295 Onwards; Publisher: Business Monitor International

BMI View: As Morocco's economic conditions improve towards the end of 2014 and the rate of decline in pharmaceutical sales slows, we hold an overall positive outlook for the market over the medium-to-long term, which will be driven by the growing middle class. However, the country's inef[...]

Lithuania Pharmaceuticals and Healthcare Report Q4 2014

Published in ; US $ 1295 Onwards; Publisher: Business Monitor International

BMI View: Collective procurement of medicines with Latvia and Estonia will benefit the development of the pharmaceutical market, albeit at the cost of pricing cuts. While these markets are singularly small, together they represent an attractive and modest-sized market. The Lithuanian mar[...]